...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Corporate Update
2
Dec 02, 2016 02:23PM
3
Dec 02, 2016 02:50PM

 SanFran,

As of today Resverlogix, but not Zenith, have published details about their webcast. So we should be expecting, at minimum, a news release for the Zenith webcast similar to the one from Resverlogix. Of course, there might be something else wrapping into that news release. We'll have to wait and see.

BearDownAZ

Share
New Message
Please login to post a reply